Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
- Cancer
- Concussions
- CRISPR
- Drug Pricing
- End of Life
- Health Disparities
- Immigration
- Opioids
- Trump
- Women’s Health
- Zika
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Neurology

Business

A veteran biopharma executive tries to fund his own product — and sees firsthand how hard it is

By Rebecca Robbins

Health

Fans ‘didn’t care if he messed up’: Glen Campbell’s doctor discusses his struggle with Alzheimer’s

By Damian Garde

advertisement

Health

A tiny part of the brain appears to orchestrate the whole body’s aging

By Jonathan Wosen

advertisement

Health

Brain disease CTE seen in most football players in large report

By Associated Press

Health

Lifestyle changes to stave off Alzheimer’s? Hints, no proof

By Associated Press

In the Lab

DARTing to the right brain cells could help research and one day patients

By Andrew Joseph

Health

When it comes to preventing dementia, not much is proved to work, says expert committee

By Sharon Begley

advertisement

First Opinion

Minority communities will be hit hardest by soaring rates of Alzheimer’s disease

By David Satcher and William A. Vega

advertisement

First Opinion

Pro athletes make fixing back pain look easy. It isn’t

By Cathryn Jakobson Ramin

Heavyweights

‘A feature, not a bug’: George Church ascribes his visionary ideas to narcolepsy

By Sharon Begley

Quick Take

Even moderate drinking may speed brain decline

By Ike Swetlitz

Health

In Washington, an alliance between symphonies and scientists

Politics

Pro-helmet activists are notching wins against motorcyclists shouting ‘freedom’

By Rebecca Robbins

Biotech

While no one says ‘cure,’ the pipeline for ALS treatments looks more promising

By Andrew Joseph

Health

In a first, scientists show a marijuana component reduces seizures for some with epilepsy

By Andrew Joseph

State of (Trump's) Mind

Trump wasn’t always so linguistically challenged. What could explain the change?

By Sharon Begley

Politics

Trump ‘is very accessible to me’: Q&A with VA Secretary David Shulkin

By Bob Tedeschi

Health

Researchers urge FDA to lower the bar — a little — on Alzheimer’s drug approvals

By Meghana Keshavan

Pharma

Lilly reports positive results on migraine drug

By Meghana Keshavan

Biotech

Amgen wants you to know that it’s not losing faith in its next big drug

By Damian Garde

In the Lab

Can zapping your neck help you quickly learn a foreign language?

By Ike Swetlitz

Health

Neuroscience’s Hatfields and McCoys debate amyloid in Alzheimer’s

By Damian Garde

Pharmalot

Washington state agency deals PTC a setback for its Duchenne drug

By Ed Silverman

First Opinion

I taught a non-MD to do brain surgery. This radical approach could solve the global surgeon shortage

By Dilan Ellegala

Business

Patients with ‘suicide headaches’ just got a new option. Will it matter?

By Rebecca Robbins

Health

Innovative housing options help autistic adults find independence

By Associated Press

Health

Before you send your spit to 23andMe, what you need to know

By Sharon Begley

First Opinion

How Obamacare saved my life

By Melanie Ormand

Health

After 40-year odyssey, first drug for aggressive MS wins FDA approval

By Ron Winslow

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine

Sign up for our morning rounds newsletter

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT